Table 1 Clinical variables for the control and study group (n = 199)
Study group (N = 70) | Control group (N = 129) | |
|---|---|---|
Independent variables | N (%) or Mean ± SD | N (%) or Mean ± SD |
OMAS | 2.21 ± 0.71 | 3 ± 0 |
NOT-S | 6.5 ± 0.71 | 1.71 ± 0.71 |
Gender | ||
male | 37 (52.9) | 69 (53.49) |
female | 33 (47.1) | 60 (46.51) |
Age | 11.81 ± 3.09 | 11.5 ± 3 |
Birtha, b | ||
Fullterm | 34 (49.28) | 112 (86.82) |
preterm | 35 (50.72) | 17 (13.18) |
Birthweighta, c | ||
normal | 32 (46.38) | 114 (88.37) |
low | 16 (23.19) | 12 (9.3) |
very low weight | 21 (30.43) | 3 (2.33) |
Type of CP | ||
spastic | 51 (72.86) | 0 |
dystonic and mixed | 19 (27.14) | 0 |
GMFCS | ||
I | 1 (1.43) | 129 (100) |
II | 26 (37.14) | 0 |
III | 1 (1.43) | 0 |
IV | 3 (4.29) | 0 |
V | 39 (55.71) | 0 |
Nutritional status | ||
eutrophy | 35 (50) | 91 (70.54) |
thinness | 4 (5.71) | 4 (3.1) |
severe thinness | 4 (5.71) | 0 |
overweight | 15 (21.43) | 21 (16.28) |
obesity | 5 (7.15) | 11 (8.53) |
severe obesity | 7 (10) | 2 (1.55) |
Use of medication (yes) | 51 (72.86) | 5 (3.88) |
Medication | ||
anticonvulsant | 31 (44.29) | 0 |
tranquilizer | 20 (28.57) | 1 (0.78) |
others | 22 (31.43) | 4 (3.1) |
Feeding | ||
alone | 35 (50) | 129 (100) |
needs help | 27 (38.57) | 0 |
gastric probe | 8 (11.43) | 0 |
Impaired health (yes) | ||
sight | 36 (51.43) | 24 (18.6) |
listening | 8 (11.43) | 2 (1.55) |
respiratory system | 21 (30) | 38 (29.46) |
cardiovascular system | 0 | 1 (0.78) |
others | 1 (1.43) | 2 (1.55) |
Cognitive | ||
normal | 0 | 129 (100) |
mild-moderate disorder | 37 (52.86) | 0 |
severe disorder | 33 (47.14) | 0 |